These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2454396)

  • 1. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus.
    Cheng SH; Piwnica-Worms H; Harvey RW; Roberts TM; Smith AE
    Mol Cell Biol; 1988 Apr; 8(4):1736-47. PubMed ID: 2454396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pp60c-src variants containing lesions that affect phosphorylation at tyrosines 416 and 527.
    Harvey R; Hehir KM; Smith AE; Cheng SH
    Mol Cell Biol; 1989 Sep; 9(9):3647-56. PubMed ID: 2476663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural elements that regulate pp59c-fyn catalytic activity, transforming potential, and ability to associate with polyomavirus middle-T antigen.
    Cheng SH; Espino PC; Marshall J; Harvey R; Merrill J; Smith AE
    J Virol; 1991 Jan; 65(1):170-9. PubMed ID: 1985196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dephosphorylation or antibody binding to the carboxy terminus stimulates pp60c-src.
    Cooper JA; King CS
    Mol Cell Biol; 1986 Dec; 6(12):4467-77. PubMed ID: 2432403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
    Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
    Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of pp60c-src and its interaction with polyomavirus middle T antigen in insect cells.
    Piwnica-Worms H; Williams NG; Cheng SH; Roberts TM
    J Virol; 1990 Jan; 64(1):61-8. PubMed ID: 2152834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation by polyoma virus middle T antigen.
    Courtneidge SA
    Cancer Surv; 1986; 5(2):173-82. PubMed ID: 2430702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of amino acids in pp60c-src that are phosphorylated by protein kinases C and A.
    Yaciuk P; Choi JK; Shalloway D
    Mol Cell Biol; 1989 Jun; 9(6):2453-63. PubMed ID: 2474754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of the amino-terminal half of polyomavirus middle-T antigen indicates that this region is the binding domain for pp60c-src.
    Markland W; Smith AE
    J Virol; 1987 Feb; 61(2):285-92. PubMed ID: 2433463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino terminus of polyomavirus middle T antigen is required for transformation.
    Cook DN; Hassell JA
    J Virol; 1990 May; 64(5):1879-87. PubMed ID: 2157858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS; Parsons JT
    Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen.
    Cartwright CA; Kaplan PL; Cooper JA; Hunter T; Eckhart W
    Mol Cell Biol; 1986 May; 6(5):1562-70. PubMed ID: 2431281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250.
    Markland W; Oostra BA; Harvey R; Markham AF; Colledge WH; Smith AE
    J Virol; 1986 Aug; 59(2):384-91. PubMed ID: 2426465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation.
    Cheng SH; Markland W; Markham AF; Smith AE
    EMBO J; 1986 Feb; 5(2):325-34. PubMed ID: 3011402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro.
    Auger KR; Carpenter CL; Shoelson SE; Piwnica-Worms H; Cantley LC
    J Biol Chem; 1992 Mar; 267(8):5408-15. PubMed ID: 1372000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.
    Kmiecik TE; Shalloway D
    Cell; 1987 Apr; 49(1):65-73. PubMed ID: 3103925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
    Roussel RR; Brodeur SR; Shalloway D; Laudano AP
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of carboxyl terminal truncation and point mutations on pp60c-src activities.
    Yaciuk P; Cannella MT; Shalloway D
    Oncogene Res; 1988 Sep; 3(2):207-12. PubMed ID: 2465526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the oncogenic activity of the cellular src protein requires the correct spacing between the kinase domain and the C-terminal phosphorylated tyrosine (Tyr-527).
    Cobb BS; Payne DM; Reynolds AB; Parsons JT
    Mol Cell Biol; 1991 Dec; 11(12):5832-8. PubMed ID: 1719372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
    Potts WM; Reynolds AB; Lansing TJ; Parsons JT
    Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.